Community Research and Development Information Service - CORDIS


HEALTHSTOCK Report Summary

Project ID: 684848

Periodic Reporting for period 1 - HEALTHSTOCK (Fodder for for HEALTHier animals and improved liveSTOCK production)

Reporting period: 2015-07-01 to 2015-12-31

Summary of the context and overall objectives of the project

PENTABIOL has developed and tested PROBISAN, a fermented fodder for nutrition of animals that overtakes the performance of any other fodder in the market. The most strict and unbiased product test has been undertaken on a single commercial swine farm in Spain comparing with the leading products in the marke) and the best performing fodder ever experienced in the farm, namely PROBIO, which was a fodder specifically engineered for this farm using probiotic additives. Each fodder was used to feed during the same period of a population of 1.575 piglets (252 each fodder).PROBISAN piglets ate 3,3% less and grew 4% more than PROBIO piglets, and ate 10% less and grew 4% morein comparison with the best in class animal feed in the market. Considering both effects PROBISAN offers 14% more yield than the market leader and 7,3% more yield than the best specially engineered product. Furthermore the average deviation of results with the group of 7 independent tests showed that PROBISAN is much more stable than the other fodders.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

The feasibility study has been carried out in a working group formed by the consultancy and the company:
• By the consultancy BANTEC GROUP, the members of the team have been the following:
- Senior consultant
- Senior consultant
• By the technology and product owner PENTABIOL, the members of the team have been the following:
- General Manager
- Process Manager
- Technical Manager
Five face-to-face meetings have been carried out with specific themes:
1. Feasibility study launch – July 2015
2. Market – September 2014
3. Value proposition, business model and commercialisation – October 2015
4. Costs, revenues and funding scheme – November 2015
5. Results validation – December 2015

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

In comparison to competition products, PROBISAN has a wider range of biologically active substances and high efficiency determined by the fermentation process, based on the combined action of yeast and a broad spectrum of microflora naturally present in the tract animal digestive, all grown on special media.
PROBISAN is more effective than probiotics in the market, which are “artificially” obtained probiotic cultures, due to PROBISAN microorganisms are bounded to the substrate and are accompanied by biologically active substances generated during consecutive fermentations.
PROBISAN will improve the welfare of animals and thus the human health, which is in line with the food security global challenges.

Related information

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top